Gene · 7518
Papers3,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-homologous End-joining Genotype, mRNA Expression, and DNA Repair Capacity in Childhood Acute Lymphocytic Leukemia. | Cancer Genomics Proteomics | 2024 | 38423600 | PubTator, text mining | PubMed |
| A di-acetyl-decorated chromatin signature couples liquid condensation to suppress DNA end synapsis. | Mol Cell | 2024 | 38423014 | PubTator, text mining | PubMed |
| Boric Acid Affects the Expression of DNA Double-Strand Break Repair Factors in A549 Cells and A549 Cancer Stem Cells: An In Vitro Study. | Biol Trace Elem Res | 2024 | 38367174 | PubTator, text mining | PubMed |
| Deposition of onco-histone H3.3-G34W leads to DNA repair deficiency and activates cGAS/STING-mediated immune responses. | Int J Cancer | 2024 | 38353495 | PubTator, text mining | PubMed |
| Sharper scissors: How TREX2 fine-tunes CRISPR-Cas9 nickases for precise editing. | Mol Ther Nucleic Acids | 2024 | 38304728 | PubTator, text mining | PubMed |
| Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration. | Genes Dis | 2024 | 38292182 | PubTator, text mining | PubMed |
| Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma. | Sci Rep | 2024 | 38287071 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a Mutagenic Factor. | Int J Mol Sci | 2024 | 38255897 | PubTator, text mining | PubMed |
| Established and Evolving Roles of the Multifunctional Non-POU Domain-Containing Octamer-Binding Protein (NonO) and Splicing Factor Proline- and Glutamine-Rich (SFPQ). | J Dev Biol | 2024 | 38248868 | PubTator, text mining | PubMed |
| Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer. | Curr Oncol | 2024 | 38248122 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype. | Discov Oncol | 2024 | 38228856 | PubTator, text mining | PubMed |
| Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions. | J Cancer | 2024 | 38213724 | PubTator, text mining | PubMed |
| SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair. | Oncogenesis | 2024 | 38191478 | PubTator, text mining | PubMed |
| ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. | Theranostics | 2024 | 38169509 | PubTator, text mining | PubMed |
| Phase separation in DNA double-strand break response. | Nucleus | 2024 | 38146123 | PubTator, text mining | PubMed |
| Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells. | Nucleic Acids Res | 2024 | 38109306 | PubTator, text mining | PubMed |
| Interactome of intact chromatosome variants with site-specifically ubiquitylated and acetylated linker histone H1.2. | Nucleic Acids Res | 2024 | 37994785 | PubTator, text mining | PubMed |
| Decline of DNA damage response along with myogenic differentiation. | Life Sci Alliance | 2024 | 37993260 | PubTator, text mining | PubMed |
| Novel PNKP mutations associated with reduced DNA single-strand break repair and severe microcephaly, seizures, and developmental delay. | Mol Genet Genomic Med | 2024 | 37916443 | PubTator, text mining | PubMed |
| Mammalian DNA ligases; roles in maintaining genome integrity. | J Mol Biol | 2024 | 37714297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7518/papers?page=5